Generic Product News (April 2018)

Pharmacy Times, April 2018 Respiratory Health, Volume 84, Issue 4

Read about the generic products featured in April.

Camber Pharmaceuticals

COMPARE TO: Celexa (Forest Laboratories, Inc)

INDICATION: Camber has launched its generic version of Celexa (citalopram) Oral Solution, indicated for the treatment of depression. Citalopram oral solution is available in a 10-mg/5-mL 240-mL bottle.

DOSAGE FORM: Oral solution

FOR MORE INFORMATION: camberpharma.com

ISOTRETINOIN CAPSULES, USPMARKETED BY: Amneal Pharmaceuticals

COMPARE TO: Accutane (Roche)

INDICATION: Amneal Pharmaceuticals has launched Isotretinoin capsules, USP, an AB-rated generic for Accutane in 10-, 20-, 30, and 40-mg strengths. Isotretinoin capsules are indicated for the treatment of severe recalcitrant nodular acne.

DOSAGE FORM: Capsules

FOR MORE INFORMATION: amneal.com

BUMETANIDE TABLETS, USPMARKETED BY: Upsher-Smith

COMPARE TO: Bumex (Hoffmann-La Roche, Inc)

INDICATION: The FDA has approved Upsher-Smith Laboratories’ abbreviated new drug application for Bumetanide tablets, the generic version of Bumex. Bumenatide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.

DOSAGE FORM: Tablets

FOR MORE INFORMATION: upsher-smith.com

MEMANTINE HYDROCHLORIDEMARKETED BY: Amneal Pharmaceuticals

COMPARE TO: Namenda XR (Allergan)

INDICATION: Amneal Pharmaceuticals has launched Memantine Hydrochloride extended-release capsules, the company’s AB-rated equivalent for Namenda XR in 7-, 14-, 21-, and 28- strengths. Namenda XR is indicated for the treatment of moderate to severe dementia of the Alzheimer type.

DOSAGE FORM: Extended-release capsules

FOR MORE INFORMATION: amneal.com